Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Low-level light therapy significantly increased hair density and thickness in people with hair loss, but they didn't notice a difference.

Scalp cooling effectively reduces hair loss from chemotherapy.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

Minoxidil and finasteride are effective for treating hair loss, with dutasteride showing potential but with side effects.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

New regenerative therapies show promise for treating hair loss.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

ALRV5XR is the most effective hair regrowth treatment at 24 weeks.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Eating too much selenium can cause bad breath, hair loss, and nail changes, with harmful effects starting at low daily doses.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

Inducing survivin in normal tissues can protect against radiation damage.

JAK inhibitors show promise for treating various skin diseases.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.